M. J. PARRY

948 total citations
27 papers, 693 citations indexed

About

M. J. PARRY is a scholar working on Organic Chemistry, Molecular Biology and Pharmacology. According to data from OpenAlex, M. J. PARRY has authored 27 papers receiving a total of 693 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Organic Chemistry, 7 papers in Molecular Biology and 6 papers in Pharmacology. Recurrent topics in M. J. PARRY's work include Synthesis and Reactions of Organic Compounds (6 papers), Inflammatory mediators and NSAID effects (6 papers) and Synthesis and pharmacology of benzodiazepine derivatives (4 papers). M. J. PARRY is often cited by papers focused on Synthesis and Reactions of Organic Compounds (6 papers), Inflammatory mediators and NSAID effects (6 papers) and Synthesis and pharmacology of benzodiazepine derivatives (4 papers). M. J. PARRY collaborates with scholars based in United Kingdom, United States and New Zealand. M. J. PARRY's co-authors include Michael J. Randall, Roger P. Dickinson, Peter E. Cross, H. M. Tyler, Kelvin Cooper, John Steele, Kenneth Richardson, M. Jonathan Fray, E. J. Corey and Thomas J. Carty and has published in prestigious journals such as The Lancet, Journal of the American Chemical Society and Journal of Medicinal Chemistry.

In The Last Decade

M. J. PARRY

26 papers receiving 620 citations

Peers

M. J. PARRY
D.L. Venton United States
Roger P. Dickinson United Kingdom
Werner Skuballa Germany
Martin F. Haslanger United States
Nathalie Ouimet Canada
William T. McElroy United States
Miyako Kato Japan
Steven A. Boyd United States
John H. Kinner United States
Carl P. Ciosek United States
D.L. Venton United States
M. J. PARRY
Citations per year, relative to M. J. PARRY M. J. PARRY (= 1×) peers D.L. Venton

Countries citing papers authored by M. J. PARRY

Since Specialization
Citations

This map shows the geographic impact of M. J. PARRY's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. J. PARRY with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. J. PARRY more than expected).

Fields of papers citing papers by M. J. PARRY

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. J. PARRY. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. J. PARRY. The network helps show where M. J. PARRY may publish in the future.

Co-authorship network of co-authors of M. J. PARRY

This figure shows the co-authorship network connecting the top 25 collaborators of M. J. PARRY. A scholar is included among the top collaborators of M. J. PARRY based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. J. PARRY. M. J. PARRY is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
PARRY, M. J.. (2016). Digital Curation in the Digital Humanities: Preserving and Promoting Archival and Special Collections. The Electronic Library. 34(6). 1055–1055. 21 indexed citations
2.
Anderson, Cynthia M., et al.. (2013). Addressing Instructional Avoidance With Tier II Supports. Journal of Applied School Psychology. 29(2). 167–182. 3 indexed citations
3.
4.
5.
Cooper, Kelvin, M. Jonathan Fray, M. J. PARRY, Kenneth Richardson, & John Steele. (1995). Enantiodifferentiation of dihydropyridine PAF antagonists. Bioorganic & Medicinal Chemistry Letters. 5(24). 3085–3090. 2 indexed citations
6.
7.
8.
PARRY, M. J., et al.. (1994). Pharmacological profile of UK-74,505, a novel and selective PAF antagonist with potent and prolonged oral activity.. PubMed. 10(3). 251–68. 16 indexed citations
9.
Cooper, Kelvin, M. Jonathan Fray, M. J. PARRY, Kenneth Richardson, & John Steele. (1992). 1,4-Dihydropyridines as antagonists of platelet activating factor. 1. Synthesis and structure-activity relationships of 2-(4-heterocyclyl)phenyl derivatives. Journal of Medicinal Chemistry. 35(17). 3115–3129. 82 indexed citations
10.
PARRY, M. J.. (1989). The role of accounting in the economic development of Bangladesh. OpenGrey (Institut de l'Information Scientifique et Technique). 4 indexed citations
11.
Corey, E. J., Chung‐Pin Chen, & M. J. PARRY. (1988). Dual binding modes to the receptor for platelet activating factor (PAF) of anti-paf trans-2,5-diarylfurans. Tetrahedron Letters. 29(24). 2899–2902. 34 indexed citations
12.
Cross, Peter E., Roger P. Dickinson, M. J. PARRY, & Michael J. Randall. (1986). Selective thromboxane synthetase inhibitors. 3. 1H-Imidazol-1-yl-substituted benzo[b]furan-, benzo[b]thiophene- and indole-2- and 3-carboxylic acids. Journal of Medicinal Chemistry. 29(9). 1637–1643. 12 indexed citations
13.
Cross, Peter E., Roger P. Dickinson, M. J. PARRY, & Michael J. Randall. (1985). Selective thromboxane synthetase inhibitors. 1. 1-[(Aryloxy)alkyl]-1H-imidazoles. Journal of Medicinal Chemistry. 28(10). 1427–1432. 30 indexed citations
14.
PARRY, M. J., et al.. (1982). A comparison of the effects of pirenzepine and atropine on gastric acid secretion, salivary secretion and pupil diameter in the rat. Life Sciences. 31(14). 1465–1471. 10 indexed citations
15.
Schaaf, Thomas, et al.. (1981). Synthesis of 11.alpha.,9.alpha.-epoxymethanothromboxane A2: a stable, optically active TxA2 agonist. Journal of the American Chemical Society. 103(21). 6502–6505. 16 indexed citations
16.
Randall, Michael J., et al.. (1981). UK-37,248, A novel, selective thromboxane synthetase inhibitor with platelet anti-aggregatory and anti-thrombotic activity. Thrombosis Research. 23(1-2). 145–162. 96 indexed citations
17.
Barnish, I. T., Peter E. Cross, Roger P. Dickinson, M. J. PARRY, & Michael J. Randall. (1981). Cerebrovasodilatation through selective inhibition of the enzyme carbonic anhydrase. 3. 5-(Arylthio)-, 5-(arylsulfinyl)-, and 5-(arylsulfonyl)thiophene-2-sulfonamides. Journal of Medicinal Chemistry. 24(8). 959–964. 9 indexed citations
18.
PARRY, M. J., et al.. (1981). UK-37,248, A Novel, Selective Thromboxane Synthetase Inhibitor With Anti-Aggregatory And Anti-Thrombotic Activity. Thrombosis and Haemostasis. 2 indexed citations
19.
Tyler, H. M., et al.. (1981). ADMINISTRATION TO MAN OF UK-37,248-01, A SELECTIVE INHIBITOR OF THROMBOXANE SYNTHETASE. The Lancet. 317(8221). 629–632. 130 indexed citations
20.
Carty, Thomas J., et al.. (1980). Piroxicam, a structurally novel anti-inflammatory compound. Mode of prostaglandin synthesis inhibition. Prostaglandins. 19(5). 671–682. 60 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by D.L. Venton Breakdown of academic impact, for papers by Roger P. Dickinson Breakdown of academic impact, for papers by Werner Skuballa Breakdown of academic impact, for papers by Martin F. Haslanger Breakdown of academic impact, for papers by Nathalie Ouimet Breakdown of academic impact, for papers by William T. McElroy Breakdown of academic impact, for papers by Miyako Kato Breakdown of academic impact, for papers by Steven A. Boyd Breakdown of academic impact, for papers by John H. Kinner Breakdown of academic impact, for papers by Carl P. Ciosek
Rankless by CCL
2026